NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
ORCHID PHARMA Share Price
ORCHPHARMA
₹1,389.65-₹55.60 (-3.85%) TodayLast updated on 04 Nov, 2024 | 15:55 IST
ORCHID PHARMA Share Price Chart
Please wait...
About ORCHID PHARMA
ORCHID PHARMA Financials
Market cap ₹7,394 Crs | Open ₹1,465.00 | Close ₹1,445.25 |
Circuit range ₹1,667.55 - ₹1,111.75 | Day range ₹1,375.95 - ₹1,465.00 | Year range ₹492.80 - ₹1,590.00 |
Volume 63,624 | Avg. traded ₹1,399.39 | Revenue (12m) ₹881 Crs |
ORCHID PHARMAOrchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.
Orchid Pharma Key indicators
52 week high ₹1,590.00 | 52 week low ₹492.80 | P/E ratio 63.7 |
P/B ratio 5.54 | ROE 9.72% | ROCE 8.96% |
Dividend yield -- | Debt/Equity ratio 0.11 | EPS 18.68 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 3 experts in the last 7 days
ORCHID PHARMA Fundamentals
ORCHID PHARMA Financial Ratios
Operating profit margin17.26% | Net profit margin11.56% |
ROE9.72% | ROA6.83% |
ROCE8.96% |
Learn more
Orchid Pharma Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹1,465.00 | ₹1,389.65 | -3.85% |
Fri, Nov 1 2024 | ₹1,468.80 | ₹1,445.25 | -0.86% |
Thu, Oct 31 2024 | ₹1,400.90 | ₹1,457.85 | |
Wed, Oct 30 2024 | ₹1,316.90 | ₹1,391.15 | |
Tue, Oct 29 2024 | ₹1,278.00 | ₹1,310.35 | |
Mon, Oct 28 2024 | ₹1,264.65 | ₹1,283.25 | |
Fri, Oct 25 2024 | ₹1,323.80 | ₹1,254.75 | -5.22% |
Thu, Oct 24 2024 | ₹1,284.05 | ₹1,323.80 |
More